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We have compared the regulation of adenylate cyclase activity in membrane fractions from C6 glioma cells 
and in monolayer cultures of C6 cells that had been permeabilized with saponin. Guanine nucleotides (GTP 
and GTPTS ) and isoproterenol increase adenylate cyclase activity in C6 membranes and in permeabilized 
C6 cells. In C6 membranes, guanine nucleotides activate adenylatc yclase in the presence or absence of 
isoproterenol; in permeabilized cells, however, guanine nucleotides increase adenylate cyclase activity only 
in the presence of isoproterenol. We suggest hat the properties of the permeabilized cells more closely 
resemble those of intact cells, and that some component which is present in permeabilized cells but is lost 
following cell disruption may be important for the normal regulation of adenylate cyclase activity. 
GTP-binding protein fl-Adrenergic receptor Receptor-effector coupling Signal transduetion 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Determination of the mechanism of adenylate 
cyclase activation has been a subject of widespread 
interest. Investigations into that mechanism have 
encompassed kinetic studies, studies with bacterial 
toxins, identification and purification of the pro- 
teins involved, the reconstitution of those proteins 
and, now, most recently, the genetics of the 
adenylate cyclase system. The proteins that have 
been investigated include receptors for hormones 
(or neurotransmitters) which stimulate or inhibit 
adenylate cyclase, the members of the GTP- 
binding protein cascade which regulate that en- 
zyme and the adenylate cyclase catalytic moiety. 
Whereas a great deal has been learned about the 
regulation of the adenylate cyclase system through 
studies with purified adenylate cyclase components 
[1] several cellular elements associated with mem- 
branes and the cytoskeleton have been observed to 
regulate adenylate cyclase, especially in neural cells 
[2,3]. The participation of various other cellular 
elements in the regulation of adenylate cyclase 
raised the possibility that this enzyme behaves dif- 
ferently in isolated membranes than in intact cells. 
We have developed an assay for adenylate 
cyclase in saponin-permeabilized C6 cells. This 
treatment makes holes of 0.1-1,urn in plasma 
membranes while retaining cell viability [4]. 
Saponin treatment allows for the free passage of 
[3zp]ATP into ceils while attached to wells in 
monolayers, and, as such, provides for the assay of 
adenylate cyclase in a nearly intact cell 
preparation. 
C62B cells were maintained in Dulbecco's MEM 
4.5 g glucose/l, 10% fetal bovine serum, in a 10% 
CO2 atmosphere. Cells were subcultured weekly in- 
to 24 well sterile plates. Permeabilization by 
saponin treatment was achieved by a modification 
of previously published methods [4]. C6 
monolayers (approx. 250000 cells/well) were 
washed three times with 200/A complete Locke's 
solution (154 mM NaC1, 2.6 mM KCI, 2.15 mM 
KzHPO4, 0.85 mM KHzPO4, 10 mM glucose, 
2 mM CaCI2, 1.0 mM MgCI2, pH 7.4) for 5 rain at 
37°C. 200 #1 saponin solution (140 mM potassium 
glutamate [KG], pH 6.8, 2 mM ATP, saponin 
[100/zg/ml]) was added for 120s at room 
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temperature. The plates were inverted, saponin 
solution drained and monolayers washed three 
times with 200,ul KG buffer. The total time for 
permeabilization and washing was 5 rain. 150,ul 
[nP]ATP (to give 2 x 10  6 cpm), 0.5 mM ATP, 
1 mM MgCI2, 0.5 mM IBMX in Hanks buffer was 
added to each well and incubated for 3 min at 
room temperature. Isoproterenol and/or GTPyS 
was added to each well and incubated 10 rain at 
37°C. Reactions were stopped with 300/xl ice-cold 
15 mM Hepes buffer, pH 7.4, and the entire plate 
was placed on dry ice for 5 min. Plates were 
removed from dry ice and allowed to thaw. Cells 
were then scraped into 1.5 ml microfuge tubes and 
wells were rinsed with 100,al Hepes buffer. Tubes 
were boiled for 8 min m a heat block and then cen- 
trifuged at 4°C for 8 rain at 15000 x g. Super- 
natants were then removed and transferred into 12 
x 75 borosilicate glass tubes; 100,al stop solution 
(2% sodium lauryl sulfate, 45 mM ATP, 1.3 mM 
3',5'-cyclic AMP), 50,al [3H]cAMP (0.02/~Ci), 
and 1 ml dH20 was added to tubes and super- 
natants decanted over Dowex columns. 
[32p]cAMP was isolated and measured by a 
modification [5] of the method of Salomon [61. 
C6 cells were grown to near confluency in 
175 cm flasks and harvested by scraping with a 
rubber policeman. Cells were collected in 15 mM 
Hepes, 0.25 M sucrose, 0.3 mM PMSF and 1 mM 
DTT, pH 7.5, and homogenized (8 strokes) in a 
teflon-glass homogenizer. 600 x g supernatants 
were collected and centrifuged three times at 
40000 x g in the homogenization buffer without 
sucrose. C6 membrane suspensions (10-20,ug pro- 
tein/assay tube) were assayed for adenylate cyclase 
activity by the method of Salomon [6], modified as 
described [5]. The assay buffer included 15 mM 
Hepes, pH 7.5, l mM DTT, 0.3 mM PMSF, 
5 mM MgCI2, 50/zM ATP, and an ATP 
regenerating system. 
3. RESULTS 
3.1. Assay of adenylate cyclase in permeabilized 
cells 
Addition of [32p]ATP to saponin-treated C6 
cells allows measurement of adenylate cyclase ac- 
tivity, rather than cAMP accumulation, in relative- 
ly intact cells. Saponin treatment results in 
90-95% of the cells taking up trypan blue, and a 
similar number are likely to have access to the 
[32p]ATP. Measurement of adenylate cyclase in 
these cells is dependent upon [32p]ATP permeabili- 
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Fig.1. Activation of C6 adenylate cyclase by isoproterenol. C6 cells were permeabilized and assayed for adenylate 
cyclase as described in section 2. Values are expressed as pmol cAMP formed per mg of total cellular protein (measured 
by the method of Bradford [7]) at each concentration of isoproterenol in the presence (o---o) or absence (o---e) of 
GTPyS, and are means of triplicate determinations (_+ SE) from one of three similar experiments. C6 membranes were 
assayed for 10 rain at 30°C in the presence (A---zx) or absence (A---A) of 5 ,uM GTPTS. Each point indicates the mean 
of a triplicate determination ( _+ SE) in one of 3 similar experiments. Note that specific activity in cells is for total cellular 
protein as opposed to membrane protein. 
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[3Zp]cAMP is generated without saponin treat- 
ment. Thus, cellular adenylate cyclase has been 
assayed in a manner similar to membranes, but 
results of these assays show distinct differences 
between cells and membranes in the regulation of 
that enzyme. 
3.2. Activation o f  C6 adenylate cyclase by 
isoproterenol 
Isoproterenol activates adenylate cyclase in 
permeabilized C6 cells as well as in C6 membranes 
(fig.l). In the presence of 5 ,aM GTP'rS, the ECso 
of isoproterenol for activation of C6 membrane 
adenylate cyclase, derived from the mean of 3 
triplicate determinations, i  approx. 95 nM which 
is comparable to that (85 nM) observed in the 
permeabilized cells. Guanine nucleotides (GTP-yS 
or GTP) do not alter the potency ol ~ isoproterenol 
in either cells or membranes. Activation of 
adenylate cyclase by isoproterenol is completely in- 
hibited by a 10-fold excess of propranotol (see 
fig.2). In permeabilized cells, isoproterenol- 
stimulated adenylate cyclase in the absence of add- 
ed guanine nucleotide (figs 1,2). In contrast, 
isoproterenol does not activate C6 membrane 
adenylate cyclase in the absence of added guanine 
nucleotide (figs 1,2). 
3.3. Activation of  C6 adenylate cyclase by G TPyS 
In the absence of isoproterenol, GTPyS- 
activated adenylate cyclase in C6 membranes, as 
has been reported [8]. We demonstrate he potency 
of GTPTS in fig.2 and observe that the EC50 for 
GTPyS is about 140 nM (average of 4 sets of 
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Fig.2. Guanine nucleotide activation of adenylate cyclase in C6 membranes and permeabilized cells. C6 membranes were 
incubated with (zx) or without (A) isoproterenol (1 #M) in the presence of indicated GTPTS concentrations. 
Permeabilized C6 cells were assayed for adenylate cyclase activity in the presence (©) or absence (e) of isoproterenol 
(1 ,aM) witb the indicated concentration f GTPyS. 10~M l-propranolol was included (m) along with isoproterenol 
(1 #M) and GTPyS (1 #M). Means of triplicate determinations (±SE) from one of 3 (cells) or 4 (membranes) similar 
experiments are depicted above. 
298 
Volume 207, number 2 FEBS LETTERS October 1986 
lriplicate determinations). GTP (not shown) is 
roughly one order of magnitude less potent 
(1.1 /zM). lsoproterenol does not alter the potency 
of guanine nucleotides, but it does increase the 
Vm,~ of adenylate cyclase activity. 
In permeabilized C6 cells, however, GTP-fS 
(fig.2) as well as GTP (not shown) do not increase 
adenylate cyclase activity (except at 10 -4 M) in the 
absence of isoproterenol. In the presence of  
isoproterenol, GTPyS potentiates adenylate 
cyclase activity markedly. The potency of GTPyS, 
in the presence of isoproterenol is comparable 
(ECs0 = 150 nM; mean of 3 sets of triplicate deter- 
minations) to that seen in C6 membranes. 
3.4. Direct effects of saponin under adenylate 
cyclase 
The possibility that the distinctions between 
permeabilized cell and C6 membrane adenylate 
cyclase were due to the treatment of cells with 
saponin required investigation. Saponin treatment 
of membranes, even at concentrations 10-fold 
higher than those used in permeabilizing cells, was 
without effect on adenylate cyclase (table 1). This 
lack of saponin effect was seen regardless of the 
presence or identity (GTPyS and/or isoproterenol) 
of the adenylate cyclase activator employed. Fur- 
thermore, when Hank's solution is substituted for 
Table 1 
Effects of saponin on C6 membrane adenylate cyclase 
Activator [Saponin] ,ug/ml 
0 10 100 
H20 9.52 9.39 9.19 
Isoproterenol 19.3 19.8 19.8 
GTPyS 83.7 83.6 86.6 
Isoproterenol + GTPyS 196.9 195,7 196.2 
Membranes were incubated with the above 
concentrations of saponin for 10 rain at 30°C and 
returned to ice. Following this, membrane suspensions 
were added to tubes containing the adenylate cyclase 
reaction mixture (see section 2) and the indicated 
activatory (GTPyS, 5 × 10 -v M; isoproterenol, 10 -6 M) 
and assayed for 10 min to determine adenylate cyclase 
activity (see section 2). The adenylate cyclase activity is 
expressed as pmol cAMP/rag protein per rain. Means of 
triplicate determinations which vary by less than 7% (see 
figs 1 and 2) are presented here 
the Hepes buffer normally used in assays of C6 
membrane adenylate cyclase, the characteristics 
for the C6 membrane adenylate cyclase remained 
the same. 
4. DISCUSSION 
Permeabilized cell techniques have been utilized 
extensively to investigate the phosphatidylinositol 
turnover system and the effects of guanine 
nucleotides on this [9] and other cellular processes 
[10]. Two previous methods have been reported 
for the assay of adenylate cyclase in permeabilized 
cells. One of these methods employed sonication 
[ 11 ] and the other used Lubrol PX or alamethecin 
[12] to permeabilize cells. Neither method was 
designed for monolayers of cells, however, and 
techniques for removing cells, such as trypsin [13] 
or EGTA [14], affect adenylate cyclase. Saponin 
treatment has been demonstrated to produce small 
'holes' in the membranes of chromaffin cells 
without affecting the overall appearance or activity 
of those ceils [4]. These results demonstrate that 
the adenylate cyclase system functions normally 
(perhaps more normally than in membranes) in 
saponin-permeabilized C6 cells. 
Perhaps the most striking finding is that GTP 
and its analogs do nothing to activate adenylate 
cyclase in permeabilized C6 cells even though they 
activate that enzyme profoundly in C6 mem- 
branes. This phenomenon is consistent with the ex- 
istence of an absolute requirement for #-receptor 
occupancy for the activation of the stimulatory 
GTP-binding protein [GNs] as has been postulated 
[15]. However, it cannot be determined from these 
data whether receptor occupancy is required for 
GTP binding to GNs, or if GTP binding is normal 
and the GNs is inactive for some other reason. 
Nucleotide-binding requirements for GN~ in- 
teracting with a ~-receptor in a reconstituted 
system have been established [16]. In that system, 
there is a residual degree of GTP binding by GNs, 
the receptor being primarily responsible for the ac- 
tivation of the GTPase rather than the activation 
of adenylate cyclase. Although we have not ad- 
dressed the question of the GTPase, preliminary 
experiments with cholera toxin (Hatta and 
Rasenick, unpublished) indicate that the lesser 
potency observed for GTP than GTPTS is due to 
greater affinity of GTPyS for GNu, rather than 
299 
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GTP hydrolysis of the former compound. Thus, 
intact C6 cells may require/Y-receptor ccupancy 
by agonist before GTP binds to GN~ and this 
property may be lost upon preparation of mem- 
branes. 
The lack of nucleotide ffects prior to receptor 
occupancy appears restricted to GNu, as 
preliminary data indicate that guanine nucleotides 
can inhibit forskolin-stimulated a enylate cyclase 
in permeabilized C6 cells, independent of agonist 
(Hughes and Rasenick, unpublished). It is not 
known whether the inhibitory GTP-binding pro- 
tein [GNi] is fundamentally different han GN~ in 
this regard, or whether the receptor independence 
of GN~ results from the lack of receptor-mediated 
inhibition of C6 adenylate cyclase under normal 
conditions [17]. 
Isoproterenol is without effect in the stimulation 
of C6 membrane adenylate cyclase. These results 
are different from those reported by Katada et al. 
[8], who observed isoproterenol-activated adenyl- 
ate cyclase without added GTP. The reasons for 
this discrepancy may be attributed to our omission 
of EGTA from the adenylate cyclase reactions 
[14]. EGTA was omitted to compare the mem- 
brane and permeabilized cell system more directly. 
However, when EGTA is present in the assay, our 
results resemble those cited above [8]. 
In both the inositol trisphosphate mediated Ca z+ 
flux in neuroblastoma cells [9] and the release of 
secretory products from mast cells [10], hydrolysis- 
resistant guanine nucleotides achieve cellular ef- 
fects without added hormone. We do not see ef- 
fects of GTPyS alone, except at 10 -4 M, on 
stimulation of the adenylate cyclase system of 
permeabilized cells. PhosphatidyIinositol hydroly- 
sis has been demonstrated in C6 cells [18] and ac- 
tivation of protein kinase C, which follows 
phosphatidylinositol hydrolysis, appears to in- 
crease platelet adenylate cyclase activity by the 
phosphorylation and subsequent inactivation of 
GNi [19]. Such a cascade may account for the 
10-4M increase in GTPTS-mediated adenylate 
cyclase activity. In Aptysia neurosecretory cells, 
pressure injection of GTPTS gives a physiological 
response similar to dibutyryl cAMP (sustained 
depolarization) only in conjunction with the ex- 
tracellular application of 5HT [20]. Intracellular 
application of GTPTS does, however, potentiate 
the effects of 5HT, and this is concordant with our 
findings in C6 cells. 
3OO 
The coupling of receptor and guanine 
nucleotide-binding proteins in the adenylate 
cyclase system has been under investigation since 
Rodbell and his colleagues [21] demonstrated a lag 
in the GppNHp activation of adenylate cyclase 
which was partially overcome by stimulatory hor- 
mones. This report represents a direct indication 
that the disruption of ceils may significantly alter 
that coupling process. We have recently proposed 
that, at least in some systems, the cytoskeleton 
might provide a constraint o the activation of  
adenylate cyclase, as cytoskeletal disrupting drugs 
augment he GNu-mediated activation of that en- 
zyme [3,22]. Although we have not yet investigated 
the role of the C6 cytoskeleton i the coupling of  
the C6 adenylate cyclase system, this provides one 
possible locus for the discrepancy between the C6 
membrane and permeabilized cell data. Certainly, 
other factors, such as membrane composition 
[22,23] and calmodulin [14] are involved as well. 
Thus, activation schemes for the adenylate cyclase 
system which do not account for these additional 
factors must be embraced with caution. 
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